AwesomeCapital
Search This Blog
Monday, June 10, 2019
Ligand Pharma (LGND) PT Lowered to $140 at Argus
Weakness Offers Buying Opportunity: analyst Jasper Hellweg
https://www.streetinsider.com/Analyst+Comments/Ligand+Pharma+%28LGND%29+PT+Lowered+to+%24140+at+Argus%2C+Weakness+Offers+Buying+Opportunity/15596431.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.